# Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions

Study · id `cardio:ct-nct06441539` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06441539](<https://clinicaltrials.gov/study/NCT06441539>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06441539

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 218 participants.

## Technical summary

Registry record NCT06441539. Randomized; no masking; primary purpose treatment. Start 2024-07-01 (anticipated); primary completion 2025-02-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 218 participants (planned count; ClinicalTrials.gov record NCT06441539, source copy `cardio:ctgov-nct06441539-2024-06-04`, retrieved 2026-10-26)
- Planned start: 2024-07-01 (anticipated) (ClinicalTrials.gov record NCT06441539, source copy `cardio:ctgov-nct06441539-2024-06-04`, retrieved 2026-10-26)
- Primary completion: 2025-02-28 (anticipated) (ClinicalTrials.gov record NCT06441539, source copy `cardio:ctgov-nct06441539-2024-06-04`, retrieved 2026-10-26)
- Completion: 2026-05-31 (anticipated) (ClinicalTrials.gov record NCT06441539, source copy `cardio:ctgov-nct06441539-2024-06-04`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06441539-2024-06-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions
- Condition: Coronary Artery Disease
- Intervention (Device): Bingo® Paclitaxel coated balloon
- Intervention (Device): Xience® Alpine Everolimus Eluting Coronary Stent System
- Lead sponsor: Yinyi(Liaoning) Biotech Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 4fce3630a91a3761eccca091d8d16d448c2399f84023bb5f68176f012087893a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
